|
Market Closed -
Bombay S.E.
06:02:27 2026-10-26 EDT
|
5-day change | 1st Jan Change | ||
| 199.20 INR | -2.11% |
|
-9.72% | +13.55% |
| Market Cap | 6.96B 73.2M 65.46M 60.56M 54.83M 103M 104M 729M 288M 3.64B 275M 269M 11.53B | P/E 2025 |
21.8x | P/E 2026 | 14.3x |
|---|---|---|---|---|---|
| Enterprise Value | 7.16B 75.3M 67.33M 62.29M 56.4M 106M 107M 750M 297M 3.75B 283M 277M 11.86B | EV / Sales 2025 |
2.88x | EV / Sales 2026 | 1.98x |
| Free-Float |
28.24% | Yield 2025 * |
-
| Yield 2026 | - |
Bombay S.E.INR
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| 524500 | Delayed | |
NSE India S.E.
| KILITCH | Delayed |
| 1 day | -2.11% | ||
| 1 week | -9.72% | ||
| Current month | -7.15% | ||
| 1 month | -10.89% | ||
| 3 months | +12.42% | ||
| 6 months | +32.14% | ||
| Current year | +13.55% |
| 1 week | 191.15 |  | 219.95 |
| 1 month | 191.15 | | 267.9 |
| Current year | 121.1 | | 267.9 |
| 1 year | 121.1 | | 267.9 |
| 3 years | 121.1 | | 267.9 |
| 5 years | 60.65 | | 267.9 |
| 10 years | 16.42 | | 267.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 73 | 1992-05-11 | |
| Director of Finance/CFO | 43 | 2021-02-28 | |
Tajouddin Ansari
COO | Chief Operating Officer | - | 2021-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | - | |
| Director/Board Member | 50 | 2007-09-28 | |
| Director/Board Member | 48 | 2014-09-29 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.11% | -9.72% | +7.68% | +56.14% | 74.95M | |
| +0.45% | +3.13% | +54.96% | +125.16% | 1,135B | |
| +0.94% | +4.93% | +39.86% | +78.72% | 635B | |
| +0.39% | +1.44% | +25.77% | +97.48% | 505B | |
| +1.43% | +4.31% | +46.20% | +67.12% | 378B | |
| -3.21% | -2.10% | +60.72% | +33.22% | 358B | |
| -0.41% | +2.64% | +22.48% | +49.82% | 295B | |
| +0.23% | +3.66% | +2.57% | +23.69% | 266B | |
| +1.22% | +4.63% | +52.40% | +64.85% | 237B | |
| +1.70% | +3.67% | +31.21% | +102.15% | 193B | |
| Average | +0.03% | +1.36% | +34.38% | +69.84% | 400.37B | |
| Weighted average by Cap. | +0.42% | +2.85% | +41.40% | +83.61% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 1.98B 20.84M 18.64M 17.24M 15.61M 29.22M 29.7M 208M 82.08M 1.04B 78.23M 76.56M 3.28B | 2.35B 24.75M 22.13M 20.48M 18.54M 34.7M 35.27M 246M 97.46M 1.23B 92.89M 90.91M 3.9B |
| Net income | 267M 2.81M 2.51M 2.32M 2.1M 3.93M 4M 27.94M 11.05M 140M 10.53M 10.31M 442M | 302M 3.17M 2.84M 2.62M 2.38M 4.45M 4.52M 31.57M 12.49M 158M 11.9M 11.65M 500M |
| Net Debt | -99.42M -1.04M -934K -864K -783K -1.46M -1.49M -10.4M -4.11M -52M -3.92M -3.84M -165M | 200M 2.1M 1.88M 1.74M 1.57M 2.94M 2.99M 20.9M 8.27M 104M 7.88M 7.71M 331M |
Employees
236
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-26 | ₹199.20 | -2.11% | 1,722 |
| 26-10-23 | ₹203.50 | +0.62% | 6,334 |
| 26-10-22 | ₹202.25 | -0.71% | 2,995 |
| 26-10-21 | ₹203.70 | -7.68% | 13,436 |
- Stock Market
- Stocks
- 524500 Stock
Select your edition
All financial news and data tailored to specific country editions
